| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |